Lavoro Limited Class A Ordinary Shares (LVRO) Dividend History

Lavoro Limited Class A Ordinary Shares (LVRO) is a company engaged in providing workforce solutions and staffing services. It specializes in connecting qualified professionals with various industries, offering employment opportunities and human resource management. The company's focus includes recruitment, workforce management, and related staffing services aimed at meeting the needs of both clients and job seekers.

Dividend History

Lavoro Limited Class A Ordinary Shares currently does not pay dividends

Company News

  • Lavoro Limited, a U.S.-listed agricultural inputs retailer in Latin America, has established a new R$310 million credit facility through a Agribusiness Credit Rights Investment Fund (FIDC-Fiagro). The proceeds will be used to support Lavoro's working capital and growth plans.

    GlobeNewswire Inc.
  • Lavoro Limited (LVRO) delivered earnings and revenue surprises of -1,400% and 20.10%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
    Featured Companies: AVO
  • Shares of The Children's Place, Inc. (NASDAQ: PLCE) moved lower during Thursday’s session following weak quarterly earnings. Children's Place posted adjusted earnings of $3.22 per share, missing market estimates of $3.56 per share. The company’s quarterly sales came in at $480.23 million versus estimates of $471.82 million, according to Benzinga Pro. Children's Place shares tumbled 25.6% to $21.23 on Thursday. Here are some other stocks moving in today's mid-day session. Gainers WaveDancer, Inc. (NASDAQ: WAVD) climbed 80.1% to $2.7201 after the company inked a definitive merger agreement with Firefly Neuroscience in an all-stock transaction. Apollomics, Inc. (NASDAQ: APLM) shares climbed 51.7% to $1.3199 after the company reported the first approval of vebreltinib for MET exon 14 skip non-small cell lung cancer. Dermata Therapeutics, Inc. (NASDAQ: DRMA) gained 29.4% to $0.8426. Dermata Therapeutics announced agreement with the U.S. FDA on the DMT310 Phase 3 clinical protocols for the treatment of acne. Janover Inc. (NASDAQ: JNVR) gained 20.1% to $0.8478. Janover announced a $1 million share repurchase program. Advent Technologies Holdings, Inc. (NASDAQ: ADN) gained 16.4% to $0.5360 as the company received funding update for €60 million to launch Green HiPo IPCEI project. SenesTech, Inc. (NASDAQ:

    Benzinga
Page data last updated 07/23/2025 01:19:22 UTC